About
AmyloiDia is a medtech company founded by researchers from Karolinska Institutet and Stockholm University that builds on our invention of a method that can detect with the ultimate, single-molecule sensitivity structured peptide/protein aggregates called amyloids, and uniquely measure their concentration and size. We focus on the implementation and further advancement of this methodology for applications in biomedical research, pharmaceutical industry and healthcare, most notably for early blood-based diagnosis of amyloid diseases such as Alzheimer's.
Technologies
Apache
Google Tag Manager
reCAPTCHA
Typekit
Mobile Friendly
Varnish
WordPress.org
Keywords
medical equipment manufacturing
amyloid nano-plaques
fluorescence correlation spectroscopy
biomolecular self-assembly
blood test
disease monitoring
biomarker development
non-immune method
amyloid detection
medical device development
nano-plaques
alzheimers disease
fluorescence fluctuation analysis
non-radioactive detection
medical devices
non-invasive testing
medical and diagnostic laboratories
spectroscopy methods
molecular diagnostics
diagnostic tools
single-molecule detection
blood-based diagnosis
single-molecule sensitivity
blood-based amyloid assay
advanced optical spectroscopy
molecular biology
molecular aggregates
pre-symptomatic diagnosis
biomarkers
early diagnosis
Company Information
-
Employees 5
-
Founded 2019
Location
Visionsgatan, Gothenburg, Vaestra Goetaland County, Sweden, 171 64
